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Abstract 
The results of preclinical studies of the new ferrodextran preparation “Ferosel T”, which contains ferrum and 
selenium, are presented. It has been established that at oral administration of ferrocellus T in a prophylactic dose 
of 2 ml/kg b.w. and the therapeutic dose of 4 ml/kg for 3 days in a row in the stomach of laboratory rats did not 
show toxic effects. No toxic effect of T ferrocellus is established at introducing it into the stomach in doses in 3 
and 10 times higher than the therapeutic ones. Under conditions of subcutaneous administration of the drug, the 
death of white rats was not observed, only short-term inhibition of laboratory animals, which was prescribed the 
drug in a dose of 10 ml/kg b.w. It was established that in the preventive and optimal therapeutic doses the drug did 
not affect the detoxification function of the liver. In rats, which ferrocellus T was administered at maximum thera-
peutic and possibly toxic doses, the duration of hexenal sleep was for 32 and 35% higher relative to control values. 
The investigation of the emotional and behavioral reactions of laboratory animals after administration of ferrocel-
lus T for 21 days in therapeutic and maximum therapeutic doses did not show a significant effect on the nervous 
system. In terms of hyperemia and swelling of the skin and the thickness of the skin, ferrocellus T in prophylactic 
and therapeutic doses upon application to rabbit skin did not cause local irritation. Separate injection of the drug 
“Ferosel T” by sub-planar way to guinea pigs in 0.1 ml. did not cause swollen reactions of the paws. As a result of 
the conducted research, no allergenic properties of the drug “Ferosel T” were found. In laboratory rats, which were 
introduced ferrosel T in the prophylactic dose of probable changes in the weight of the heart, liver, spleen and 
kidneys is not established. In rats, which were administered ferrocellus T in an optimal therapeutic dose, in com-
parison with control weights of the spleen and liver, respectively, was in 10.3 and 6.4% higher. When introducing 
ferrocellus T at the maximum therapeutic dose, the mass of the spleen and liver was in 14.0 and 15.0% higher, 
respectively. The results of the studies indicate that the drug “Ferosel T” is safe when used for the prevention and 
treatment of animals. 
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1. Introduction
According to reports in the literature, with the intensive 
introduction of pigs on an industrial basis, in the absence of 
timely prophylactic measures, the disease of newborn pig-
lets to ferrum-deficient anemia is 100%, and death reaches 
35% (Zimmermann, 1995; Lee and Downing, 1979; Rytych 
et al., 2012; Ohorodnyk, 2013; Berezovskyi et al., 2013; 
Starzyński et al., 2013; Danchuk et al., 2013; Pu et al., 2015; 
Hunchak et al., 2018). In order to conduct the treatment and 
prevention of ferrum deficiency anemia of piglets, we have 
proposed a new ferro dextran drug “Ferosel T” (ferrocellus 
T) – an analogue of the officinal preparation “Ferrovet 
7.5%”, from which the ferrocellus-T is different in the pres-
ence of sodium selenite in it (Todoriuk et al., 2016).  
According to the Decree of the Department of Veterinary 
Medicine “Toxicological control of new means of animal 
protection”, approved by the Main Department of Veteri-
nary Medicine of the Ministry of Agriculture and Food of 
Ukraine as of December 16, 1996, each new preparation 
recommended for the treatment of animals must meet the 
following requirements: 
• the new drug, in comparison with the analogue prod-
uct, should exhibit higher therapeutic efficacy; 
• it must not be toxic to the animals while it is used on
them; 
• the drug or its metabolites should not affect the sani-
tary quality and nutritional value of livestock products; 
• in the manufacture and the use of the preparation, it
should not cause harm to the environment. 
For the treatment and prevention of ferrum deficiency 
anemia of piglets, we proposed a new saline ferro dextran 
drug “Ferosel T” – an analogue of the officinal preparation 
“Ferrovet 7.5%”, from which the ferrocellus T is different 
by the presence of sodium selenite (Todoriuk et al., 2016). 
According to our requirements, we conducted experi-
mental studies on acute and chronic toxicity (Gutyj et al.,  
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2017; 2018), pharmacological action and pharmacotherapeu-
tic efficacy of ferrocellus T at spontaneous ferrum deficiency 
anemia of piglets. 
Taking into account the fact that the toxicity of the com-
ponents of the drug Ferosel T, in particular Ferrum and 
Selenium, is already known and published in the literature 
(Gutyj et al., 2016; Khariv et al., 2016; Martyshuk et al., 
2016; Khariv et al., 2017; Sobolev et al., 2018), we investi-
gated the acute and chronic toxicity of Ferosel T as a whole, 
for oral and parenteral administration, and studied its effect 
on the detoxification function of the liver. 
2. Materials and methods
Experiments on the determination of acute toxicity of 
ferrocellus T were performed on 50 laboratory rats (males 
and females) weighing 270–320 g. While using oral admin-
istration, the experiments were performed on 25 laboratory 
white rats, which were divided into 5 groups of 5 head in 
each. Ferrocellus T was injected to the experimental rats 
daily, 3 days in a row, with a metal probe through the mouth 
in prophylactic, therapeutic, maximal therapeutic and possi-
bly toxic doses (Table 1). Rats of the control group (5 ani-
mals) were injected daily, during 3 days in a row, 15 ml/kg 
of isotonic sodium chloride solution into the stomach. 
The experiments to determine the acute toxicity of ferro-
cellus T for parenteral administration were performed on 25 
laboratory white rats, which were divided into 5 groups of 5 
animals in each. Rats subcutaneously, daily for 3 consecu-
tive days, were introduced ferrocellus T in the prophylactic, 
therapeutic, maximal therapeutic and possibly toxic doses. 
The observation of laboratory animals were conducted 
for 7 days after the introduction of the drug. In the first day 
of the experiment, the animals were under constant surveil-
lance. The following indicators were taken into account: 
general condition, appearance, intensity and character of 
mobile activity, coordination of movements, peculiarities of 
animal behavior, presence of a convulsions, reaction to 
external stimuli (tactile, sound, light), state of hair cover and 
visible mucous membranes, relation to forage, rhythm, fre-
quency of breathing, time of occurrence and character of 
intoxication, its severity, course, time of death of animals or 
their recovery. 
The influence of ferrocellus T on the detoxification func-
tion of the liver was studied in 20 white rats (males and 
females) weighing 270–320 g. The rats were divided into 4 
groups (5 in each): 
Rats of the first group (control) subcutaneously were in-
jected isotonic sodium chloride solution in a dose of 6 ml/kg 
b.w.;
Rats of the second group (D1) subcutaneously were in-
jected ferrocellus T in the prophylactic dose – 1 ml/kg b.w. 
(75 mg/kg of ferrum, 0.3 mg/kg of selenium); 
Rats of the third group (D2) subcutaneously were inject-
ed ferrocellus T at a therapeutic dose of 2 ml/kg b.w. (150 
mg/kg of ferrum, 0.6 mg/kg of selenium); 
Fourth group rats (D3) subcutaneously were injected fer-
rocellus T at the maximum therapeutic dose of 6 ml/kg b.w. 
(450 mg/kg of ferrum, 1.8 mg/kg of selenium). 
At 31st day since the start of the drug administration on 
5 white rats from each group, the definition of the detoxify-
ing function of the liver was determined using a hexenal test 
(Rozin, 1964). The laboratory animals received intraperito-
neally 1% solution of hexenal in a dose of 45 mg/kg for this 
purpose. Then the average sleep time was recorded from the 
moment when the animal took a side position for sleep. 
The irritant effect of ferrocellus T on the skin was stud-
ied on 12 rabbits. The skin was shaved equal 6 cm2 on the 
backs of animals and degreased with ethyl alcohol. Gauze 
tampon was rubbed in ferrocellus T in the skin using such 
doses: prophylactic – 1 ml/kg b.w. (first group), therapeutic 
optimal – 2 ml/kg (second group), therapeutic maximum – 6 
ml/kg (third group). Rats of the control group were rubbed 
in the isotonic sodium chloride solution at a dose of 6 ml/kg. 
After 6, 24 and 48 hours after application of ferrocellus T, 
the irritating effect of the presence (absence) hyperemia and 
edema of the skin and skin fold thickness were determined, 
which is measured by a micrometer. Pain reaction of ani-
mals to the drug was determined by palpation of the place of 
application of “Ferosel” T. 
Experiments on the study of allergenic properties of fer-
rocellus T were carried out on guinea pigs weighing 500–
560 g. Due to the lack of irritant effect of the ferrocellus T, 
the testing of allergenic properties was performed by detect-
ing itching and edema in the animals sensitized with this 
drug. 
Guinea pigs (n = 6) were twice injected into a conjuncti-
val sac of 0.05 ml of “Ferosel” T. Control animals (n = 6) 
were injected with a sterile isotonic sodium chloride solu-
tion. 12 hours later. Repeatedly in a conjunctival sac, 0.05 
ml of “Ferosel T” (test), isotonic sodium chloride solution 
(control) was cemented. 
The irritant effect of the ferrocellus T on the mucous 
membrane of the eye was studied on 3 rabbits. In a conjunc-
tival sac of the left eye, using the pipette animals were 
dipped in 2 drops of the drug. To control the right eye, ani-
mals were dipped in 2 drops of isotonic sodium chloride 
solution. The animal was fixed, the angle of the conjugate 
bag was pulled out and the tear-nasal duct was pressed over 
the finger for 1 minute. The irritant effect of ferrocellus T 
was determined by the presence (absence) of hyperemia of 
the conjunctiva, by the injection of blood vessels, by the 
state of sclera, cornea, and eyelids. 
3. Results and discussion
Setting parameters of acute drug toxicity. Acute toxicity 
is a harmful effect of a drug that occurs after its single or 
repeated administration in short (at least 4 hours) intervals 
during the day. 
During the study of acute toxicity of the drug “Ferosel 
T” it was necessary: 
- to establish toxic doses or side effects of the drug for a 
single oral and parenteral administration in the prophylactic, 
therapeutic, maximum therapeutic, possibly toxic doses 
(Fig. 1); 
- to investigate the effect of the newly developed drug at 
the indicated doses on the detoxification function of the liver 
by the method of “hexenal test”. 
Parameters of acute toxicity of ferrocellus T for intro-
duction into the stomach of white rats are given in Table. 1. 
Clinical observations of experimental and control rats 
were carried out for 7 consecutive days. During the trial 
period, clinical signs of toxic effects of the ferrocellus T in 
the doses studied by us have not been established in animals. 
The general condition of experimental animals was the same 
as in the control animals. Forage and water consumption 
were within normal limits. The faeces were without devia-
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tions from the normal consistency and smell. The reaction of 
animals to sound and tactile stimuli is adequate. There was 
no death of animals. 
At day 7 of the experiment, the animals were decapitated at 
a light etheric anesthetic. At the section of the visible chang-
es in the internal organs was not observed. Thus, the drug 
“Ferosel T” in prophylactic and therapeutic doses and in a 
dose of 3 times greater than the therapeutic, for oral admin-
istration to laboratory rats for 3 consecutive days did not 
show toxic effects. 
Fig. 1. The research to determine the acute toxicity 
Table 1 
Indicators of the preparation "Ferosel T" toxicity at the administration to stomach of white rats 
Group of 
animals 
Amount of animals in a 
group Preparation dose, ml/kg 
Amount of dead animals 
total in % Average time of death 
C 5 – 0 0 0 
D1 5 2 0 0 0 
D2 5 4 0 0 0 
D3 5 12 0 0 0 
D4 5 20 0 0 0 
The next stage of the study was to determine the acute 
toxicity of ferrocellus T for parenteral administration to 
laboratory rats (Table 2). 
It has been established that after subcutaneous admin-
istration in prophylactic and therapeutic doses, even at a 
dose that is in 3 times higher than the therapeutic, ferrocel-
lus T did not show toxic effects on laboratory rats. The gen-
eral condition, food intake and reaction to external stimuli in 
experimental animals were the same as in the control ani-
mals. 
At day 7 of the experiment, the animals were decapitated 
using a slight etheric anesthesia. At the intersection of visi-
ble pathoanatomical changes in internal organs was not 
observed. In the injection site of the ferrocellus T the color-
ing of the hypodermic tissue was light brown in color due to 
the presence of residual amounts of dextran that was not 
completely adsorbed. 
Under conditions of subcutaneous administration, no 
death of white rats was observed, only the short-term inhibi-
tion of laboratory animals was observed, which was pre-
scribed the preparation in a dose of 10 ml/kg bodyweight, 
which is due to the introduction into the body of a large 
amount of the drug, and in particular sodium selenite (Ta-
ble 2). 
Thus, in prophylactic, therapeutic doses and possibly 
toxic for a single dose subcutaneous injection for 3 consecu-
tive days, ferrocellus T did not cause toxic effects on labora-
tory rats. 
Acute toxicity of Ferosel T 
for oral administration 
prophylactic 
2 ml/kg b.w. (for the preparation it is 
150 mg/kg Ferum,0.60 mg/kg 
Selenium) 
1 ml/kg b.w. for drug  
(75 mg/kg Ferum, 0.3 mg/kg 
Selenium) 
therapeutic 
4 ml/kg b.w.  
(for the preparation – 300 mg/kg 
Ferum, 1.20 mg/kg Selenium) 
2 ml/kg b.w. for the preparation 
(150 mg/kg Ferum, 0.6 mg/kg 
Selenium) 
probably toxic 
20 ml/kg b.w.(1500 mg/kg Ferum, 
6.0 mg/kg Selenium) 
10 ml/kg b.w. (750 mg/kg Ferum, 
3.0 mg/kg Selenium) 
maximal therapeutic 
12 ml/kg b.w. (900 mg/kg Ferum, 
3.60 mg/kg Selenium) 
6 ml/kg for drug 
(450 mg/kg Ferum, 
1.8 mg/kg Selenium) 
15 ml/kg isotonic sodium 
chloride solution 
6 ml/kg b.w. isotonic sodium 
chloride solution control 
for parenteral administration 
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Table 2 
Indicators of the toxicity of the preparation "Ferosel T" at the subcutaneous injection to white rats 
Group of 
animals 
Amount of animals in a 
group Preparation dose, ml/kg 
Amount of dead animals 
total in % Average time of death 
C 5 – 0 0 0 
D1 5 1 0 0 0 
D2 5 2 0 0 0 
D3 5 6 0 0 0 
D4 5 10 0 0 0 
Influence of “Ferosel T” on the detoxification function 
of the liver. The liver plays an important role in many types 
of metabolism, protein synthesis, performs detoxification 
and excretory functions. By disposing of toxic substances, 
liver cells become the target of their action (Gutyj et al., 
2017; Kryshtalska et al., 2017).  
The influence of the ferrodextran preparations on the an-
titoxic function of the liver was studied by hexenal test. The 
basis of this method is the ability of various chemicals to 
influence the duration of hexenal sleep in laboratory ani-
mals, and as it is known, hexenal is completely metabolized 
in the liver. 
Table 3 








(mg/kg) Length of sleep (min) for: 
C Control – – 27,6 ± 1.5 
D1 Prophylactic 75 0.3 28,2 ± 1.3 
D2 Therapeutic optimal 150 0.6 27,8 ± 1.5 
D3 Therapeutic maximal 450 1.8 36.4 ± 1.4* 
D4 Possible toxic 750 3.0 37.2 ± 1.3** 
Note: degree of probability: * – Р < 0.05; ** – Р < 0.01. 
After the introduction of ferrocellus T at the indicated 
doses in the control and experimental groups, caused the 
pharmacological sleep by hypodermic hexenal injection at a 
dose of 60 mg/kg b.w. 
It is known that the duration of hexenal sleep in animals 
depends on the ability of the microsomal liver enzymes to 
neutralize hexenal by means of glucuronization. Usually in 
clinically healthy rats, at a normal functional state of the 
liver, the sleep lasts 25–30 minutes. 
The length of the animal's sleep was deducted from the 
moment they were taken by the side position to the first 
attempts to change it, and expressed in minutes. 
It was found that after subcutaneous administration of 
ferrocellus T, hexenal sleep in control and experimental rats 
(C, D1, D2) lasted from 27.6 ± 1.5 to 28.2 ± 1.3 min. Conse-
quently, in the prophylactic and optimal therapeutic doses, 
the drug did not affect the detoxification function of the 
liver. 
In rats of D3 and D4 groups, which were administered the 
ferrocellus T at maximum therapeutic and possibly toxic 
doses, the duration of hexenal sleep was in 32 and 35% 
higher relative to control values. We believe that a longer 
sleep was a consequence of the toxic effects of sodium sele-
nite on the liver. Selenium has a hepatotropic effect. 
Determination of chronic toxicity of a ferrocellus T. The 
purpose of determining the chronic toxicity of a ferrocellus 
T is to detect the harmful effects of the drug in cases of its 
long-term administration into the body of experimental 
animals. In this case, it matters the detection of the most 
sensitive of its organs and systems, and the establishment of 
inverse recovery of functions against the background of the 
drug being studied. 
After repeated administration, the drug may be irritant or 
cause allergic reactions, alter the functional state of the 
reproductive organs, affect the embryonic development of 
the fetus in the womb or show teratogenic or carcinogenic 
effects. 
The toxicity of the ferrocellus T was studied according 
to the irritant action (skin and conjugate samples), the aller-
gic action (skin application method), and the coefficients of 
the mass of the internal organs for long-term administration 
of the drug were determined. 
During the period of research on the determination of 
chronic toxicity of ferrocellus T, no probable changes in the 
behavior of experimental animals were observed (Table 4). 
The appetite of all experimental and control group of rats 
was satisfactory. In animals that were fed with ferrocellus T 
at a dose of 10 ml/kg for 21 days, motor activity decreased. 
Investigation of the emotional and behavioral reactions of 
laboratory animals after administration of ferrocellus T for 
21 days in therapeutic and maximum therapeutic doses did 
not show a significant effect on the nervous system. 
Under these conditions, a tendency towards inhibition 
was observed in animals receiving ferrocellus T in a dose of 
10 ml/kg, characterized by a decrease in motor activity 
(number of crossed squares), examination (number of stand-
ing poses), boobyme (number of washings). At the same 
time, the orientative-experimental (number of sniffs and 
glances) and emotional (number of defecations) reaction did 
not differ from that of all experimental groups (D1, D2, D3 
and D4) and control group. 
The clinical status of animals in the experimental and 
control groups in the course of the experiment remained 
within the limits of the physiological norm. 
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Table 4 
Indicators of the physiological state and activity of laboratory rats for 21 daily introduction of the ferrocellus T 
(M ± m; n = 10) 
Group of 
animals Preparation in a dose Appetite 
Behavioral reaction (number of 
holes that the animal sniffed) 
Vertical motor activity (number of 
heights on the hind limbs) 
C (isotonic sodium chloride solution 6 ml/kg) Sufficient The hole reflex is saved 10.20 ± 0.51 
D1 1 ml/kg Sufficient The hole reflex is saved 10.65 ± 0.50 
D2 2 ml/kg Sufficient The hole reflex is saved 10.70 ± 0.45 
D3 6 ml/kg Sufficient The hole reflex is saved   9.98 ± 0.60 
D4 10 ml/kg Sufficient The hole reflex is saved   9.57 ± 0.62 
Table 5 
Characteristics of the local irritant action of the drug  
“Ferosel T”, with a single effect on the skin of the rabbits 
(M ± m; n = 3) 
Density of applica-
tion, ml/cm2 
Average mark of expressiveness 
Group 1 Group 2 Group 3 Group 4 
swelling 
0.020 0 0 0 0 
0.040 0 0 0 0 
0.060 0 0 0 0 
0.080 0 0 0 0 
0.100 0 0 0 0 
0.120 0 0 0 0 
erythema 
0.020 0 0 0 0 
0.040 0 0 0 0 
0.060 0 0 0 0 
0.080 0 0 0 0 
0.100 0 0 0 0 
0.120 0 0 0 0 
Irritant effect of the drug “Ferosel T”. It was established 
that the parameters of hyperemia and edema of the skin and 
the thickness of the skin folded ferrocellus T in prophylactic 
and therapeutic doses upon application to the rabbit skin did 
not cause local irritation (Table 5–6). 
While studying the reaction of conjunctiva to ferrocellus 
T, after 30 min, 1, 3, 6, 12, 24 and 48 hours after instillation 
of the drug for the parameters we studied, the irritant effect 
of the ferrocellus T was not observed (Table 7). 
Consequently, “Ferosel T” has no irritating properties 
when used externally.  
Allergic properties of the drug “Ferosel T”. Separate in-
jection of “Ferosel T” subplanetary to guinea pigs (n = 6) in 
0.1 ml did not induce swelling of the paws, which differs 
from the similar reaction to the administration of isotonic 
sodium chloride solution (n = 6) (Table 8). 
As a result of the conducted research, no  allergenic 
properties of the drug “Ferosel T” were found. 
The experiment showed a lack of reaction of the con-
junctiva of sensitized and intact guinea pigs in 1 and 
24 hours for instillation of the drug (Table 8). 
Table 6 
The thickness of the skin folds of rabbits after application of the ferrocellus T (M ± m; n = 3) 
№ Group of animals Ferosel-T (dose) 
The thickness of the skin folds, mm 
6 hours 24 hours 48 hours 
1 Control (C) – 6 ml/kg b.w. (isotonic sodium chloride solution) 2.04 ± 0.03 2.06 ± 0.05 2.07 ± 0.04 
2 Prophylactic (D1) 1 ml/kg b.w.  2.08 ± 0.03 2.08 ± 0.03 2.07 ± 0.05 
3 Therapeutic optimal (D2) 2 ml/kg b.w. 2.06 ± 0.02 2.06 ± 0.03 2.05 ± 0.04 
4 Therapeutic maximal (D3) 6 ml/kg b.w. 2.03 ± 0.05 2.05 ± 0.03 2.06 ± 0.04 
5 Probable toxic (D4) 10 ml/kg b.w. 2.05 ± 0.04 2.07 ± 0.03 2.06 ± 0.03 
Table 7 
Influence of Ferosel T on Conjunctivitis, Cornea and Eyelid of the Rabbit's Eye (M ± m; n = 3) 
Experiment time 
Rabbits of group № 1 Rabbits of group № 2 Rabbits of group № 3 
Evaluation 
in points Irritant effect 
Evaluation 
in points Irritant effect 
Evaluation 
in points Irritant effect 
Before administration 0 Absent 0 Absent 0 Absent 
After 30 min. 0 Absent 0 Absent 0 Absent 
After 1 hours 0 Absent 0 Absent 0 Absent 
After 3 hours 0 Absent 0 Absent 0 Absent 
After 6 hours 0 Absent 0 Absent 0 Absent 
After 12 hours 0 Absent 0 Absent 0 Absent 
After 24 hours 0 Absent 0 Absent 0 Absent 
After 48 hours 0 Absent 0 Absent 0 Absent 
Ukrainian Journal of Veterinary and Agricultural Sciences, 2018, Vol. 1, N 1 
8 
Table 8 
Frequency of detection of hypersensitivity in guinea pigs 
after intradermal administration of ferrocellus T by conjunc-




0 After 1 hour After 24 hours 
Ferosel T 6/6 0/6 0/6 
Isotonic solution of 
sodium chloride 6/6 0/6 0/6 
 Swelling of the paws 
Ferosel T 0/6 6/6 0/6 
Isotonic solution of 
sodium chloride 0/6 6/6 0/6 
 
Influence of Ferosel T on the coefficients of mass of in-
ternal organs. Experiments were performed on 25 laborato-
ry rats weighing 270–320 g. Within 30 days, animals re-
ceived ferrocellus T subcutaneously at intervals of 7 days 
(4 injections) at the following doses: prophylactic – 1 ml/kg 
b.w., therapeutic optimum – 2 ml/kg Therapeutic maximum 
– 6 ml/kg, possibly toxic – 10 ml/kg. Rats of the control 
group, at intervals of 7 days, subcutaneously were injected 
isotonic sodium chloride solution in a dose of 6 ml/kg. 
During the animal experiment, clinical observations 
were performed. At the 30th day, the animals were decapi-
tated using a light etheric anesthesia and the coefficients of 
the mass of the internal organs were determined (Table 9). 
In laboratory rats, which received ferrocellus T in a 
prophylactic dose, in comparison with control probable 
changes in cardiac, liver, spleen, and kidney mass factors 
were not present. 
In rats, which were administered ferrocellus T in an optimal 
therapeutic dose, in comparison with control weights of the 
spleen and liver, respectively, was in 10.3 and 6.4% higher. 
When administering ferrocellus T at the maximum therapeu-
tic dose, the mass of the spleen and liver was in 14.0% and 
15.0% higher respectively. 
 
Table 9 
The coefficients of the mass of the internal organs of the laboratory rats after the introduction of the ferrocellus T  
(M ± m; n = 5) 
 
№ Group of animals Ferosel-T (dose) 
Mass of the internal organs (g) 
Heart Spleen Liver Kidneys 
1 Control (C) 3.80 ± 0.18 3.30 ± 0.15 30.20 ± 1.0 7.34 ± 0.25 
2 Prophylactic (D1) 1 ml/kg  3.76 ± 0.10 3.35 ± 0.13 30.15 ± 1.1 7.36 ± 0.30 
3 Therapeutic optimal (D2) 2 ml/kg 3.78 ± 0.15 3.64 ± 0.10** 32.13 ± 1.2 7.32 ± 0.20 
4 Therapeutic maximal (D3) 6 ml/kg  3.76 ± 0.11 3.76 ± 0.16* 34.75 ± 1.0** 7.28 ± 0.22 
5 Probable toxic (D4) 10 ml/kg  3.75 ± 0.10 3.81 ± 0.12* 35.14 ± 1.1** 7.21 ± 0.21 
Note: The degree of probability in relation to control: * – P < 0.05, ** – P < 0.01. 
 
The cardiac and kidney mass coefficients of the se-
cond and third group of rats did not indicate a probable 
difference with respect to control. We believe that after 
prolonged administration of “Ferosel T” to rats in ther-
apeutic doses (optimal, maximal and possibly toxic), 
an increase in the mass of the liver and spleen occurred 
as a result of the strengthening of the functional state 




At the oral administration of ferrocellus T in a prophy-
lactic dose of 2 ml/kg b.w.(which is Ferrum – 150 mg/kg, 
Selenium – 0.6 mg/kg) and a therapeutic dose of 4 ml/kg 
(Ferrum – 300.0 mg/kg, Selenium – 1.2 mg/kg) while ad-
ministrating for 3 days in a row in the stomach of laboratory 
rats toxic effects do not appear. No toxic effect of the ferro-
cellus T has been established, as well as its introduction into 
the stomach in doses 3 and 10 times higher than the thera-
peutic ones. 
While the subcutaneous administration of ferrocellus T 
during 3 days in a row in a prophylactic dose, optimal thera-
peutic, maximum therapeutic and in a dose in 5 times higher 
than the therapeutic, the drug did not cause toxic effects on 
laboratory rats. 
In experiments with the determination of hexenal sleep, 
it was found that in preventive and optimal therapeutic dos-
es, ferrocellus T did not affect the detoxification function of 
the liver. In the therapeutic maximum dose, the drug in the 
first 6 hours after administration slightly reduced the detoxi-
fication function of the liver due to sodium selenite, which 
at a dose of 1.2 mg/kg shows hepatotropic effect. 24 hours 
after the introduction of the ferrocellus T, the detoxification 
function of the liver spontaneously completely restored. 
In the study of chronic toxicity it has been established 
that ferrocellus T does not act irritatively on the skin and 
mucous membranes and does not show an allergic effect on 
the organism of animals after multiple applications. 
In optimal and maximum therapeutic doses, Ferosel T 
increased by 14% the mass of the spleen, which occurred as 
a result of the activation of erythropoiesis in it, and in-
creased the weight of the liver by 15% as a result of the 
strengthening of the Bilexynthesis function in it. Along with 
this, due to the strengthening of the functional state of these 
organs, there is an influx of blood, which also increases the 
mass of internal organs. 
According to the classification of toxic substances 
(DOST 12.1.007-76), in terms of the degree of danger to 
animals, the Ferosel T as a whole and its component, ferrum 
sulfate, are classified as toxic grade 4 (low toxicity sub-
stances). The second component of the Ferosel T – sodium 
Ukrainian Journal of Veterinary and Agricultural Sciences, 2018, Vol. 1, N 1 
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selenite is classified as grade 4 toxicity (moderately toxic 
substances). 
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